Compare Gold Fields Limited (GFI) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gold Fields Limited vs Medpace Holdings Inc — how do they compare? Gold Fields Limited trades at $36.82 (market cap $31.87B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Gold Fields Limited is the larger of the two by market cap, and Gold Fields Limited pays a 6% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gold Fields Limited for 49 Days and Medpace Holdings Inc for 14 Days on average.
| GFI | MEDP | |
|---|---|---|
Market Cap | $31.87B | $16.82B |
Volume | 4,169,651 | 223,093 |
Sector | Basic Materials | Health |
52-Week High | $61.52 | $630.19 |
52-Week Low | $31.25 | $393.42 |
Typical Hold Time | 49 Days | 14 Days |
Enterprise Value | $32.47B | $16.44B |
Dividend Yield | 6% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gold Fields (GFI) trades at $36.82, up 5.05% today, amid mixed technical signals with a bearish overall trend. Fundamentally, the company shows strong profitability with 38.66% net margins and robust cash flow generation of $3.77B from operations in 2025. Recent news highlights the rejected $27B Northern Star takeover bid and strong operational performance from Salares Norte, driving investor attention to the company's capital allocation strategy.
The investment outlook balances strong fundamentals against acquisition risks and technical weakness. With 44% analyst buy ratings and a $52.75 price target suggesting 43% upside, GFI presents value opportunity, though recent earnings misses and bearish technicals warrant caution. Key risks include execution on growth projects and gold price volatility.
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
